HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toshiyuki Enomoto Selected Research

Myxococcus xanthus antibiotic TA

2/2011Antibiotic time-lag combination therapy with fosfomycin for postoperative intra-abdominal abscesses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toshiyuki Enomoto Research Topics

Disease

9Neoplasms (Cancer)
07/2022 - 10/2005
4Colorectal Neoplasms (Colorectal Cancer)
01/2017 - 01/2008
3Neoplasm Metastasis (Metastasis)
01/2020 - 10/2005
2Stomach Neoplasms (Stomach Cancer)
01/2018 - 10/2006
2Rectal Neoplasms (Rectal Cancer)
09/2017 - 01/2017
2Hemorrhage
06/2016 - 01/2014
2Pathologic Constriction (Stenosis)
10/2015 - 06/2011
2Acute Cholecystitis
12/2014 - 03/2013
1Ependymoma
01/2021
1Appendicitis
04/2020
1Abscess
04/2020
1Glioma (Gliomas)
03/2020
1Pericardial Effusion
01/2018
1Edema (Dropsy)
01/2018
1Dyspnea (Shortness of Breath)
01/2018
1Acute Subdural Hematoma
06/2016
1Brain Injuries (Brain Injury)
06/2016
1Subdural Hematoma (Subdural Hemorrhage)
06/2016
1Hematoma
06/2016
1Craniocerebral Trauma (Head Injury)
06/2016
1Colitis
10/2015
1Rupture
01/2014
1False Aneurysm (Pseudoaneurysm)
01/2014
1Pancreatic Fistula (Pancreatic Fistulas)
01/2014
1Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
02/2011
1Abdominal Abscess
02/2011
1Skin Neoplasms (Skin Cancer)
01/2009
1Wounds and Injuries (Trauma)
01/2008
1Anemia
01/2007
1Breast Neoplasms (Breast Cancer)
10/2005

Drug/Important Bio-Agent (IBA)

2IodineIBA
05/2012 - 01/2009
1Melanocyte-Stimulating Hormones (MSH)IBA
07/2022
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
07/2022
1SolutionsIBA
01/2021
1MeglumineFDA Link
01/2021
1CAM 5.2 antigenIBA
01/2021
1Glucose (Dextrose)FDA LinkGeneric
01/2021
1Histones (Histone)IBA
03/2020
15'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA
03/2020
1Enhancer of Zeste Homolog 2 ProteinIBA
03/2020
1Keratins (Keratin)IBA
10/2018
1VimentinIBA
10/2018
1stable plasma protein solutionIBA
09/2017
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2017
1Fluorouracil (Carac)FDA LinkGeneric
01/2017
1Anti-Bacterial Agents (Antibiotics)IBA
02/2011
1FosfomycinFDA Link
02/2011
1Myxococcus xanthus antibiotic TAIBA
02/2011
1Tumor Biomarkers (Tumor Markers)IBA
01/2007
1doxifluridineIBA
10/2006
1Paclitaxel (Taxol)FDA LinkGeneric
10/2006
1anti-synaptophysinIBA
01/2006
1ChromograninsIBA
01/2006
1AntibodiesIBA
01/2006

Therapy/Procedure

4Therapeutics
01/2017 - 10/2006
4Stents
12/2016 - 01/2014
2Radiotherapy
01/2020 - 03/2019
2Drug Therapy (Chemotherapy)
01/2018 - 10/2006
2Gastrectomy
01/2018 - 10/2006
2Laparoscopic Cholecystectomy
12/2014 - 03/2013
1Cesarean Section (Caesarean Section)
01/2022
1Appendectomy
04/2020
1Pancreatectomy
03/2019
1Splenectomy
03/2019
1Punctures
01/2018
1Proctectomy
09/2017
1Chemoprevention
01/2017
1Colectomy
01/2017
1Neoadjuvant Therapy
01/2017
1Decompression
06/2016
1Minimally Invasive Surgical Procedures
06/2016
1Craniotomy
06/2016
1Conversion to Open Surgery
12/2014
1Pancreaticoduodenectomy
01/2014
1Self Expandable Metallic Stents
06/2011
1Laparotomy
01/2008
1Hepatectomy
10/2005
1Mastectomy (Mammectomy)
10/2005
1Operative Surgical Procedures
10/2005